Synthetic lethality occurs when the combination of mutations in two or more genes leads to cell death, whereas a mutation in only one of these genes does not, providing a targeted approach for cancer therapy by exploiting specific genetic vulnerabilities in tumor cells. This concept is pivotal in developing treatments that selectively kill cancer cells while sparing normal cells, enhancing therapeutic precision and reducing side effects.